Tania Aparecida Sartori Sanchez Bachega

ASSOCIATE PROFESSOR at FMUSP (2010), accredited at the Postgraduate Service of FMUSP - in the areas of concentration of Endocrinology and Internal Medicine. She is currently an assistant physician at the Hospital das Clínicas, Faculty of Medicine, USP and outpatient coordinator of adrenal hyperplasia at the same establishment. Graduated in Medicine from the University of Santo Amaro (1987). She holds a DOCTORATE (1997), POST-DOCTORATE (2001) and DOCÊNCIA Exam (2007) in Endocrinology from the Faculty of Medicine of the University of São Paulo; all theses addressed the line of research on diagnosis, molecular and therapeutic aspects of congenital adrenal hyperplasia (CAH). She carried out scientific improvement in molecular biology at the University of California/USA, in the Dept. of Pediatrics (2006). Co-Editor of Archives of Endocrinology & Metabolism and reviewer of the following journals: The Journal of Clinical Endocrinology and Metabolism, Clinical Endocrinology (Oxford), Expert Reviews in Molecular Medicine, Molecular Genetics and Metabolism. Experience in medicine, researches with an emphasis on clinical medicine, mainly in hyperandrogenic diseases, such as CAH due to 21-hydroxylase deficiency. Completed the supervision of 07 Scientific Initiation students, 04 master's students, 07 doctoral students and co-supervision of 01 doctoral student; Principal Researcher of two Thematic Projects with FAPESP Support, one concluded in October 2011 and the other approved in 2021, she was also the coordinator of another 04 FAPESP Research Grants. All graduate students (completed and/or in progress) received an individual scholarship from FAPESP or CNPq and two of them are professors at public universities. Effective Member in 3 International Committees: 1) Multicenter Study Group on the Non-Classical Form of 21-Hydroxylase Deficiency (sponsored by CARES Foundation), 2) Committee for the Creation of Conducts for the Classical Form of 21-Hydroxylase Deficiency ( National Institute of Health and CARES Foundation) and 3) European Multicenter Group Ï-CAH?. Since 2012, she has been an advisor to the Ministry of Health in the implementation of the Neonatal Screening of Congenital Adrenal Hyperplasia in the national territory. The CAH line of research on neonatal screening, especially data on comorbidities related to late diagnosis without screening, directly contributed to the inclusion of CAH in the National Neonatal Neonatal Screening Program (PNTN) in 2012. Acting as vice president of the Brazilian Society of Neonatal Screening and Inborn Errors of Metabolism in 2019 and president since 2021, she was one of the cooperators in scientific advice for law 14,154, which expands the neonatal screening for more than 50 diseases in the PNTN in 2021, since then has been offering long-term courses through SBTEIM, free for the training of health professionals. On July 5, 2022, she received an award for her performance in neonatal screening in Brazil, at the ?Newborn Screening World View, Internaional Summit?, in Turcu, Finland. (Source: Lattes Curriculum)